Cibus Inc. Receives USDA Approval for Herbicide Tolerance Trait HT2 in Canola, Marking Seventeenth Regulatory Achievement

Reuters
06 Jun
Cibus Inc. Receives USDA Approval for Herbicide Tolerance Trait HT2 in Canola, Marking Seventeenth Regulatory Achievement

Cibus Inc., a leading agricultural technology company, announced that the United States Department of Agriculture's Animal and Plant Health Inspection Service (USDA-APHIS) has designated its latest herbicide tolerance trait (HT2) in Canola as "not regulated." This decision is part of USDA's Biotechnology Regulatory Services $(BRS.UK)$ and reflects Cibus' ongoing momentum in developing advanced agricultural traits. The HT2 trait is designed to improve weed management in broad acre crops like Canola and Soybean, offering a novel solution to combat herbicide-resistant weeds. This designation adds to Cibus' portfolio, bringing the total number of their traits considered "not regulated" to seventeen. The approval underscores Cibus' commitment to enhancing agricultural productivity and sustainability.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cibus Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9464620-en) on June 06, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10